Please use this identifier to cite or link to this item:
|Title:||Lowered testosterone in male obesity: mechanisms, morbidity and management.||Austin Authors:||Fui, Mark Ng Tang;Dupuis, Philippe;Grossmann, Mathis||Affiliation:||Department of Medicine Austin Health, University of Melbourne, Melbourne; Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia||Issue Date:||4-Mar-2014||Publication information:||Asian Journal of Andrology; 16(2): 223-31||Abstract:||With increasing modernization and urbanization of Asia, much of the future focus of the obesity epidemic will be in the Asian region. Low testosterone levels are frequently encountered in obese men who do not otherwise have a recognizable hypothalamic-pituitary-testicular (HPT) axis pathology. Moderate obesity predominantly decreases total testosterone due to insulin resistance-associated reductions in sex hormone binding globulin. More severe obesity is additionally associated with reductions in free testosterone levels due to suppression of the HPT axis. Low testosterone by itself leads to increasing adiposity, creating a self-perpetuating cycle of metabolic complications. Obesity-associated hypotestosteronemia is a functional, non-permanent state, which can be reversible, but this requires substantial weight loss. While testosterone treatment can lead to moderate reductions in fat mass, obesity by itself, in the absence of symptomatic androgen defi ciency, is not an established indication for testosterone therapy. Testosterone therapy may lead to a worsening of untreated sleep apnea and compromise fertility. Whether testosterone therapy augments diet- and exercise-induced weight loss requires evaluation in adequately designed randomized controlled clinical trials.||Gov't Doc #:||24407187||URI:||http://ahro.austin.org.au/austinjspui/handle/1/12031||DOI:||10.4103/1008-682X.122365||URL:||https://pubmed.ncbi.nlm.nih.gov/24407187||Type:||Journal Article||Subjects:||Evidence-Based Medicine
Hormone Replacement Therapy
Testosterone.administration & dosage.blood.therapeutic use
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 29, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.